Tyco/Bard
This article was originally published in The Gray Sheet
Executive Summary
Ongoing discussions between Tyco and the Securities and Exchange Commission regarding the anti-trust implications of its $3.2 bil. agreement to buy C.R. Bard will push the anticipated closing date for the merger from Jan. 31 to March 31 (1"The Gray Sheet" Nov. 19, 2001, In Brief)...
You may also be interested in...
Tyco/C.R.Bard
Ongoing discussions with the Federal Trade Commission regarding Tyco's pending acquisition of Bard under a $3.2 bil. May deal will delay completion, which is now not expected before the first quarter of 2002, Bard says. The merger, which had been expected to close by year-end, likely has drawn scrutiny of overlap in the urology field, mainly in areas such as Foley catheters, and could result in a possible divestiture of part of the business...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.